Select Medical Holdings Corp. Files 8-K
Ticker: SEM · Form: 8-K · Filed: Oct 31, 2024 · CIK: 1320414
Sentiment: neutral
Topics: financial-results, corporate-events
TL;DR
SELECT MEDICAL HOLDINGS CORP FILED AN 8-K ON OCT 31, 2024, COVERING FINANCIALS AND OTHER EVENTS.
AI Summary
Select Medical Holdings Corp. filed an 8-K on October 31, 2024, reporting on its results of operations and financial condition, as well as other events. The filing also includes financial statements and exhibits. The company's principal executive offices are located at 4714 Gettysburg Road, Mechanicsburg, PA 17055.
Why It Matters
This 8-K filing provides an update on Select Medical Holdings Corp.'s financial performance and significant corporate events, which is crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on financial results and events, not indicating any immediate or significant risks.
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORP (company) — Registrant
- October 31, 2024 (date) — Date of earliest event reported
- 4714 Gettysburg Road, Mechanicsburg, PA 17055 (location) — Address of principal executive offices
- 717-972-1100 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What are the 'Other Events' mentioned in the filing?
The filing lists 'Other Events' as an item information category, but the specific events are not detailed in the provided text.
When was this 8-K report filed?
The report was filed on October 31, 2024.
What is the primary business of Select Medical Holdings Corp?
Select Medical Holdings Corp. is in the 'SERVICES-HOSPITALS' industry, SIC code 8060.
Where are Select Medical Holdings Corp.'s principal executive offices located?
The principal executive offices are located at 4714 Gettysburg Road, Mechanicsburg, PA 17055.
Filing Stats: 566 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-10-31 16:41:05
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
- $0.125 — f Directors declared a cash dividend of $0.125 per share. The dividend will be payable
Filing Documents
- tm2427100d1_8k.htm (8-K) — 30KB
- tm2427100d1_ex99-1.htm (EX-99.1) — 328KB
- tm2427100d1_ex99-1img001.jpg (GRAPHIC) — 10KB
- tm2427100d1_ex99-1img002.jpg (GRAPHIC) — 5KB
- 0001104659-24-113096.txt ( ) — 576KB
- sem-20241031.xsd (EX-101.SCH) — 3KB
- sem-20241031_lab.xml (EX-101.LAB) — 33KB
- sem-20241031_pre.xml (EX-101.PRE) — 22KB
- tm2427100d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On October 31, 2024, Select Medical Holdings Corporation (the "Company") issued a press release announcing its financial results for its third quarter ended September 30, 2024. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
01 Other Events
Item 8.01 Other Events Dividend Declaration On October 30, 2024, the Company's Board of Directors declared a cash dividend of $0.125 per share. The dividend will be payable on or about November 26, 2024 to stockholders of record as of the close of business on November 13, 2024.
01 F inancial
Item 9.01 F inancial (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated October 31, 2024, announcing financial results for the third quarter ended September 30, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. SELECT MEDICAL HOLDINGS CORPORATION Date: October 31, 2024 By: /s/ Michael E. Tarvin Michael E. Tarvin SeniorExecutive Vice President, General Counsel and Secretary